UMQVC members will be at the 23rd annual conference of ISOQOL for oral communications and a poster:

  • Friday, 21 october

Poster #2009 : Erlotinib added to bevacizumab as maintenance therapy and health-related quality of life in patients with metastatic colorectal cancer: results of the GERCOR DREAM phase III trial. Amélie Anota, Dewi Vernerey, Christophe Tournigand, Benoist Chibaudel, Benoit Samson, Werner Scheithauer, David Brusquant, Thierry André, Aimery de Gramont, Franck Bonnetain

Oral Session 210: Statistical Methods

4:20 pm – 4:33 pm Impact on time until deterioration of health-related quality of life of a first-line therapy combining ABI-007 and gemcitabine or simplified LV5FU2 in patients with metastatic pancreatic cancer: results of clinical phase II trial AFUGEMEmilie Charton, Jean-Baptiste Bachet, Benoist Chibaudel, Pierre Validire, Pascal Hammel, Thierry André, Christophe Louvet, Amélie Anota, Franck Bonnetain

4:34 pm – 4:47 pm Impact of the occurrence of missing data on the time to health-related quality of life score deterioration: a simulation studyAmélie Anota, Francesco Cottone, Fabio Efficace, Franck Bonnetain

  • Saturday, 22 october

Oral Session 301: Response Shift

4:51 pm – 5:04 pm Impact of the occurrence of a response shift on the determination of the minimal clinically important difference in a health-related quality of life score over timeAhmad Ousmen, Thierry Conroy, Francis Guillemin, Michel Velten, Damien Jolly, Mariette Mercier, Sylvain Causeret, Jean Cuisinier, Olivier Graesslin, Zeinab Hamidou, Franck Bonnetain, Amélie Anota

Link to ISOQOL conference website

About Amélie ANOTA

Amélie Anota is a research engineer in biostatistics. She passed a master’s degree in mathematics for computer graphics and statistics at the University of Burgundy. She defended in 2014 a PhD in Biostatistics at the University of Franche-Comté. Her PhD research focused on the methodology of longitudinal analysis of health-related quality of life data in oncology. She is statistician for the French National Platform Quality of Life and Cancer since 2011. She realizes longitudinal statistical analysis of health-related quality of life data from oncology clinical trials and also realizes validation of the psychometrics properties of some health-related quality of life questionnaires.

2015-2017 © Copyright -

Website by Pearlweb